Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bakker

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Molecular Pharmacology|April 25, 2007
Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endotheliumSigridur A Asgeirsdóttir, Jan A A M Kamps, Hester I Bakker, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 3, 2020
Completeness of tuberculosis (TB) notification: inventory studies and capture-recapture analyses, six European Union countries, 2014 to 2016Masja Straetemans, Mirjam I Bakker, Sandra Alba, et al.
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|February 28, 2013
Variability of bioaccessibility results using seventeen different methods on a standard reference material, NIST 2710Iris Koch, Kenneth J Reimer, Martine I Bakker, et al.
Tropical Medicine and Infectious Disease|May 27, 2022
Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden CountriesLiza M de Groot, Masja Straetemans, Noriah Maraba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 14, 2017
Defining the research agenda to measure and reduce tuberculosis stigmasK Macintyre, M I Bakker, S Bergson, et al.
Nanoimpact|May 31, 2024
Governance of advanced materials: Shaping a safe and sustainable futureMonique Groenewold, Eric A J Bleeker, Cornelle W Noorlander, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Molecular Pharmacology|April 25, 2007
Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endotheliumSigridur A Asgeirsdóttir, Jan A A M Kamps, Hester I Bakker, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 3, 2020
Completeness of tuberculosis (TB) notification: inventory studies and capture-recapture analyses, six European Union countries, 2014 to 2016Masja Straetemans, Mirjam I Bakker, Sandra Alba, et al.
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|February 28, 2013
Variability of bioaccessibility results using seventeen different methods on a standard reference material, NIST 2710Iris Koch, Kenneth J Reimer, Martine I Bakker, et al.
Tropical Medicine and Infectious Disease|May 27, 2022
Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden CountriesLiza M de Groot, Masja Straetemans, Noriah Maraba, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 14, 2017
Defining the research agenda to measure and reduce tuberculosis stigmasK Macintyre, M I Bakker, S Bergson, et al.
Nanoimpact|May 31, 2024
Governance of advanced materials: Shaping a safe and sustainable futureMonique Groenewold, Eric A J Bleeker, Cornelle W Noorlander, et al.
Pageof 9